The study of ccRCC demonstrated that SETD2 mutation causes loss of H3K36 trimethylation and consequently leads to altered chromatin accessibility and widespread defects in transcript processing that eventually result in promotion of cancer development [23, 44]. This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.